Close

Michael G. Surette, PhD

Professor, Department of Medicine

Joint appointment to the Department of Biochemistry and Biomedical Sciences

Canada Research Chair in Interdisciplinary Microbiome Research

Email: surette@mcmaster.ca

Lab website: http://www.surettelab.ca

twitter: @surette_m

Google+: +Mike Surette

 

Bacteria live almost exclusively in communities with other microorganisms, and often in association with multicellular hosts. These communities are capable of maintaining complex structural and functional stability over time, and exhibit fascinating properties of resiliency in response to environmental changes. This is a result of interactions between microbes and the environment and amongst members of the community. A multitude of chemical interactions occur in microbial communities where primary and secondary metabolites contribute to a wealth of interactions between organisms. The chemicals include a variety of nutrients, toxic or neutral metabolic byproducts, antibiotics, and cell-cell signaling molecules. These chemical and physical signals mitigate microbial relationship that can be competitive, cooperative or neutral, and thus are responsible for determining community structure. In turn, the surrounding community changes the microenvironment of individual cells that respond to chemical and environmental cues in a combinatorial manner.  Pathogens must contend with this complex ecology during infection.  For pathogens, these other microbes are the normal microbiota of the human host (the human microbiome).  The human microbiome is poorly defined and composed of thousands of organisms of which relatively few have been characterized.  We are working to define the normal microbiota and to understand the role of small molecule signaling in the ecology of the normal microbiota of the human host.

One of our primary areas of research investigates the role of normal flora-pathogen interactions in health and disease in the area of respiratory infections with a focus in cystic fibrosis.  A polymicrobial perspective on these infections has lead to identification of overlooked pathogens in airway disease as well as synergistic interactions between avirulent organisms and pathogens.  This is a fundamentally different view of airway infections and has lead to direct benefits to patients through altered treatment strategies.

  1. Surette, MG, Bowdish, DME. Loss of Microbial Topography Precedes Infection in Infants. Am. J. Respir. Crit. Care Med. 2019; :. doi: 10.1164/rccm.201903-0687ED. PubMed PMID:30978299 .
  2. Wang, H, Kwon, YH, Dewan, V, Vahedi, F, Syed, S, Fontes, ME et al.. TLR2 Plays a Pivotal Role in Mediating Mucosal Serotonin Production in the Gut. J. Immunol. 2019; :. doi: 10.4049/jimmunol.1801034. PubMed PMID:30952815 .
  3. Caminero, A, McCarville, JL, Galipeau, HJ, Deraison, C, Bernier, SP, Constante, M et al.. Duodenal bacterial proteolytic activity determines sensitivity to dietary antigen through protease-activated receptor-2. Nat Commun. 2019;10 (1):1198. doi: 10.1038/s41467-019-09037-9. PubMed PMID:30867416 PubMed Central PMC6416356.
  4. Heirali, AA, Acosta, N, Storey, DG, Workentine, ML, Somayaji, R, Laforest-Lapointe, I et al.. The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome. J. Cyst. Fibros. 2019; :. doi: 10.1016/j.jcf.2019.02.010. PubMed PMID:30857926 .
  5. Kwon, YH, Wang, H, Denou, E, Ghia, JE, Rossi, L, Fontes, ME et al.. Modulation of Gut Microbiota Composition by Serotonin Signaling Influences Intestinal Immune Response and Susceptibility to Colitis. Cell Mol Gastroenterol Hepatol. 2019;7 (4):709-728. doi: 10.1016/j.jcmgh.2019.01.004. PubMed PMID:30716420 .
  6. Ooi, CY, Syed, SA, Rossi, L, Garg, M, Needham, B, Avolio, J et al.. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation. Sci Rep. 2018;8 (1):17834. doi: 10.1038/s41598-018-36364-6. PubMed PMID:30546102 PubMed Central PMC6292911.
  7. Lamarche, D, Johnstone, J, Zytaruk, N, Clarke, F, Hand, L, Loukov, D et al.. Microbial dysbiosis and mortality during mechanical ventilation: a prospective observational study. Respir. Res. 2018;19 (1):245. doi: 10.1186/s12931-018-0950-5. PubMed PMID:30526610 PubMed Central PMC6286574.
  8. Whelan, FJ, Rossi, L, Stearns, JC, Surette, MG. Culture and Molecular Profiling of the Respiratory Tract Microbiota. Methods Mol. Biol. 2018;1849 :49-61. doi: 10.1007/978-1-4939-8728-3_4. PubMed PMID:30298247 .
  9. Hayes, CL, Dong, J, Galipeau, HJ, Jury, J, McCarville, J, Huang, X et al.. Commensal microbiota induces colonic barrier structure and functions that contribute to homeostasis. Sci Rep. 2018;8 (1):14184. doi: 10.1038/s41598-018-32366-6. PubMed PMID:30242285 PubMed Central PMC6155058.
  10. Klein, TA, Pazos, M, Surette, MG, Vollmer, W, Whitney, JC. Molecular Basis for Immunity Protein Recognition of a Type VII Secretion System Exported Antibacterial Toxin. J. Mol. Biol. 2018;430 (21):4344-4358. doi: 10.1016/j.jmb.2018.08.027. PubMed PMID:30194969 PubMed Central PMC6193138.
Search PubMed
Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedIn